Correspondingly, in the current study, a statistically significant 1.5 or more-fold increase in SCCHN risk was associated with all the mutant genotypes of rs13181 (ERCC2), viz. The gene discussed is ERCC2; the disease is head and neck squamous cell carcinoma.